Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies. Smith N, Beckerman R Value Health. 2014 Nov; 17(7):A809. PMID: 27203058. Abstract CommentRecommendBookmarkWatch